FDA Sets Goals That May Put Vaccine Out of Reach Before Vote (3)

Oct. 6, 2020, 7:53 PM

The U.S. Food and Drug Administration plans to have an expert panel review any Covid-19 vaccine application for emergency use, and wants to see at least two months of safety data, the agency said Tuesday.

The requirements will almost certainly add to the time it will take to review any vaccine, potentially past President Donald Trump’s goal of having one by Election Day next month. While the FDA has said it plans to work as quickly as possible, it has also said it won’t cut scientific corners or bend to political pressure to rush a vaccine.

Pfizer Inc., ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.